APA

Bosch J. J., Iheagwara U. K., Reid S., Srivastava M. K., Wolf J., Lotem M., Ksander B. R. & Ostrand-Rosenberg S. (20091125). Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells. : Cancer immunology, immunotherapy : CII.

Chicago

Bosch Jacobus J, Iheagwara Uzoma K, Reid Sarah, Srivastava Minu K, Wolf Julie, Lotem Michal, Ksander Bruce R and Ostrand-Rosenberg Suzanne. 20091125. Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells. : Cancer immunology, immunotherapy : CII.

Harvard

Bosch J. J., Iheagwara U. K., Reid S., Srivastava M. K., Wolf J., Lotem M., Ksander B. R. and Ostrand-Rosenberg S. (20091125). Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells. : Cancer immunology, immunotherapy : CII.

MLA

Bosch Jacobus J, Iheagwara Uzoma K, Reid Sarah, Srivastava Minu K, Wolf Julie, Lotem Michal, Ksander Bruce R and Ostrand-Rosenberg Suzanne. Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells. : Cancer immunology, immunotherapy : CII. 20091125.